Fatigue News and Research

RSS

UTA researcher aims to develop assistive robots to help people with spinal cord injuries

A University of Texas at Arlington computer science researcher is developing a robotic system that helps people with spinal cord injuries perform everyday tasks, and she's involving members of the UTA Movin' Mavs wheelchair basketball team in the effort.

4 Nov 2022

Moderna's COVID-19 vaccine safe and effective in children 6 months to 5 years of age

Moderna's COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found.

4 Nov 2022

Vaccinations against COVID-19 lead to higher antibody concentrations in persons with vaccine reactions

After the second and third vaccinations against COVID-19, a significantly higher antibody concentration has been confirmed, while tolerability was good.

4 Nov 2022

Persistent COVID-19 symptoms among South Africans infected during SARS-CoV-2 Beta, Delta and Omicron variant waves

Researchers longitudinally followed up hospitalized (H) and non-hospitalized (NH) COVID-19 patients for six months after laboratory-confirmed SARS-CoV-2 infections to identify factors that increase the risk of post-COVID-19 condition development in the South African population.

4 Nov 2022

Poll: More than half of people over 50 are a critical source of health help for older loved ones

More than half of people over 50 say they've helped at least one person over 65 take care of their health, personal hygiene, home or finances in the past two years, a new University of Michigan poll finds.

3 Nov 2022

Extensive European study finds very high rates of long-COVID

In a recent study published by the European Center for Disease Prevention and Control, researchers assessed the prevalence of post-coronavirus disease 2019 (COVID-19) condition symptoms.

1 Nov 2022

COVID-19 positive hearts may be safe for transplantation

A recent study soon to be presented at the American Heart Association (AHA) Scientific Sessions 2022* suggests that hearts from coronavirus disease 2019 (COVID-19)-positive (COVID-19+) donors may be safe for transplantation.

1 Nov 2022

Cohort study determines how often COVID-19 symptoms recurred

Researchers at University of California San Diego School of Medicine, with colleagues from the ACTIV-2 trial, part of the U.S. government's response to COVID-19, investigated whether symptoms of COVID-19 recurred following a two-day symptom-free period in persons who did not receive any treatment for the disease.

1 Nov 2022

Johns Hopkins researchers uncover a possible target to treat sleep apnea

In a new study with obese mice, Johns Hopkins Medicine researchers say they have added to evidence that specialized channel proteins are possible therapeutic targets for sleep apnea and similar abnormally slow breathing disorders in obese people.

31 Oct 2022

COVID-19-positive donor hearts appear to be safe for transplantation

Donor hearts from people who were COVID-19-positive appeared to be as safe for transplantation as those from people without COVID-19, according to a short-term analysis to be presented at the American Heart Association's Scientific Sessions 2022.

31 Oct 2022

Investigators study symptom trajectories in nondialysis-dependent CKD patients

When individuals with varying degrees of chronic kidney disease who were not on dialysis answered annual questionnaires about their symptoms, researchers found that one-third could be categorized as having a "Worse symptom score and worsening trajectory" of symptoms.

30 Oct 2022

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

In a recent study published in the journal JAMA Network Open, researchers in the United States estimated the sociodemographic factors associated with and prevalence of post-acute coronavirus disease 2019 (COVID-19) symptom sequelae (PASC) or long COVID (LCOVID).

30 Oct 2022

Standard cutoff point for low testosterone levels may not be accurate for young men

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).

28 Oct 2022

Long COVID, a new clinical entity constantly evolving

Researchers discuss the epidemiology, diagnosis, pathogenesis, and treatment of long COVID.

27 Oct 2022

In mild cases of COVID, blood clot risk is higher

Researchers examine the association between COVID-19 and increased cardiovascular outcomes and mortality sequelae.

27 Oct 2022

Researchers report white matter differences in post-treatment Lyme disease patients

In a study using specialized imaging techniques, Johns Hopkins Medicine researchers report distinctive changes in the "white matter" and other brain tissue physiology of those with post-treatment Lyme disease, a condition affecting 10% to 20% of the nearly half a million Americans who contract Lyme disease annually.

26 Oct 2022

Fatigue News and Research

UTA researcher aims to develop assistive robots to help people with spinal cord injuries

Moderna's COVID-19 vaccine safe and effective in children 6 months to 5 years of age

Vaccinations against COVID-19 lead to higher antibody concentrations in persons with vaccine reactions

Persistent COVID-19 symptoms among South Africans infected during SARS-CoV-2 Beta, Delta and Omicron variant waves

Poll: More than half of people over 50 are a critical source of health help for older loved ones

Extensive European study finds very high rates of long-COVID

COVID-19 positive hearts may be safe for transplantation

Cohort study determines how often COVID-19 symptoms recurred

Johns Hopkins researchers uncover a possible target to treat sleep apnea

COVID-19-positive donor hearts appear to be safe for transplantation

Investigators study symptom trajectories in nondialysis-dependent CKD patients

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

Standard cutoff point for low testosterone levels may not be accurate for young men

Long COVID, a new clinical entity constantly evolving

In mild cases of COVID, blood clot risk is higher

Researchers report white matter differences in post-treatment Lyme disease patients

What is the association of self-reported post-vaccination symptoms with anti–SARS-CoV-2 antibody response?

MRI shows structural changes in the brain associated with functional, nonepileptic seizures

Researchers characterize and predict post-acute sequelae of SARS-CoV-2 infection

Ivermectin is ineffective in non-severe COVID-19 patients according to new study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News